About Blue Heron Bio
Blue Heron Bio is a company based in Bothell (United States) founded in 1999 was acquired by Eurofins Genomics in August 2019.. Blue Heron Bio has raised $3.68 million across 1 funding round from investors including OriGene, Eurofins Genomics and Life Technologies. Blue Heron Bio offers products and services including Gene Synthesis, Gene Fragments, Plasmid Prep, and Oligo Synthesis. Blue Heron Bio operates in a competitive market with competitors including GSK, Avidity Biosciences, Poseida Therapeutics, Senti Biosciences and Sutro Biopharma, among others.
- Headquarter Bothell, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Blue Heron Biotech, Llc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$3.68 M (USD)
in 1 rounds
-
Latest Funding Round
$3.68 M (USD), Series D
Jan 16, 2007
-
Investors
OriGene
& 4 more
-
Employee Count
Employee Count
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Blue Heron Bio
Blue Heron Bio offers a comprehensive portfolio of products and services, including Gene Synthesis, Gene Fragments, Plasmid Prep, and Oligo Synthesis. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Service for custom gene creation with fast turnaround for research.
Rapid production of DNA fragments for various applications.
Preparation of high-quality plasmids for experimental use.
Synthesis of oligonucleotides for research and sequencing.
Funding Insights of Blue Heron Bio
Blue Heron Bio has successfully raised a total of $3.68M through 1 strategic funding round. The most recent funding activity was a Series D round of $3.68 million completed in January 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series D — $3.7M
-
First Round
First Round
(16 Jan 2007)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2007 | Amount | Series D - Blue Heron Bio | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Blue Heron Bio
Blue Heron Bio has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include OriGene, Eurofins Genomics and Life Technologies. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Tools and technologies for biotech and biopharma research were supplied.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Blue Heron Bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Blue Heron Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Blue Heron Bio Comparisons
Competitors of Blue Heron Bio
Blue Heron Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Poseida Therapeutics, Senti Biosciences and Sutro Biopharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
|
|
| domain | founded_year | HQ Location |
Cell-based therapies for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Blue Heron Bio
Frequently Asked Questions about Blue Heron Bio
When was Blue Heron Bio founded?
Blue Heron Bio was founded in 1999 and raised its 1st funding round 8 years after it was founded.
Where is Blue Heron Bio located?
Blue Heron Bio is headquartered in Bothell, United States. It is registered at Bothell, Washington, United States.
Is Blue Heron Bio a funded company?
Blue Heron Bio is a funded company, having raised a total of $3.68M across 1 funding round to date. The company's 1st funding round was a Series D of $3.68M, raised on Jan 16, 2007.
What does Blue Heron Bio do?
Blue Heron Bio was founded in 1999 and is based in Bothell, United States. Operations center on biotechnology, with services focused on DNA design, gene synthesis, and sequencing. The proprietary Genemaker Technology platform is utilized to handle complex sequences, including large genes, hairpins, repeats, and GC-rich DNA. These capabilities support research and development in the life sciences sector.
Who are the top competitors of Blue Heron Bio?
Blue Heron Bio's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
What products or services does Blue Heron Bio offer?
Blue Heron Bio offers Gene Synthesis, Gene Fragments, Plasmid Prep, and Oligo Synthesis.
Who are Blue Heron Bio's investors?
Blue Heron Bio has 5 investors. Key investors include OriGene, Eurofins Genomics, Life Technologies, Integra Ventures, and Taraval Associates.